Stephen M. Ansell
-
- Lymphoma Diagnosis and Treatment 8
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Oncology top 10%
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
- Vascular Tumors and Angiosarcomas 1
- HER2/EGFR in Cancer Research 1
- Neurology top 10%
- Neuroblastoma Research and Treatments 1
-
- Immune Cell Function and Interaction 3
- Co-authors
- Thomas E. WitzigCandido E. RiveraIvana N. MicallefThomas M. HabermannLuis F. PorrataDavid J. InwardsBetsy LaPlantCarrie A. Thompson
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Stephen M. Ansell
10 papers receiving 431 citations
Peers
Comparison fields: 5 of 36
- Pathology and Forensic Medicine 302
- Genetics 150
- Oncology 312
- Neurology 145
- Immunology 62
Countries citing papers authored by Stephen M. Ansell
This map shows the geographic impact of Stephen M. Ansell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Ansell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Ansell more than expected).
Fields of papers citing papers by Stephen M. Ansell
This network shows the impact of papers produced by Stephen M. Ansell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Ansell. The network helps show where Stephen M. Ansell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen M. Ansell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2018 | 9 | |
| 3 | 2016 | 7 | |
| 4 | 2015 | 33 | |
| 5 | 2014 | 268 | |
| 6 | 2012 | 11 | |
| 7 | 2006 | 1 | |
| 8 | 2005 | 13 | |
| 9 | 2002 | 5 | |
| 10 | 2001 | 88 |
About Stephen M. Ansell
Stephen M. Ansell is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 10 papers that have together received 436 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Vascular Tumors and Angiosarcomas (1 paper), HER2/EGFR in Cancer Research (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (302 citations), Genetics (150 citations) and Oncology (312 citations). Stephen M. Ansell has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Thomas E. Witzig, Candido E. Rivera, Ivana N. Micallef, Thomas M. Habermann, Luis F. Porrata, David J. Inwards, Betsy LaPlant, Carrie A. Thompson, Patrick B. Johnston and Grzegorz S. Nowakowski. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.